Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | CA3 | P07451 | 2/20 | 0.32 |
| ▸ | CA5A | P35218 | 2/20 | 0.32 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | CA6 | P23280 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8959182 | 0.77 | MEN1 (0.33) | CA2MEN1KMT2A | |
| SCHEMBL7771624 | 0.77 | CA2 (0.42) | CA2ALDH1A1POLBSMN1; SMN2MEN1 | |
| SCHEMBL10340592 | 0.72 | SMN1; SMN2 (0.35) | ALDH1A1POLBSMN1; SMN2MEN1KMT2A | |
| SCHEMBL7771467 | 0.72 | EPHX1 (0.38) | CA2ALDH1A1POLBSMN1; SMN2MEN1 | |
| SCHEMBL7771082 | 0.69 | EPHX1 (0.40) | CA2ALDH1A1POLBSMN1; SMN2MEN1 | |
| SCHEMBL7769364 | 0.66 | EPHX1 (0.46) | ALDH1A1POLBSMN1; SMN2MEN1KMT2A | |
| SCHEMBL15603817 | 0.65 | — | — | |
| SCHEMBL8528148 | 0.65 | CA2 (0.40) | CA2ALDH1A1POLBSMN1; SMN2MEN1 | |
| SCHEMBL9733225 | 0.64 | CA2 (0.35) | CA2 | |
| SCHEMBL2884635 | 0.64 | CA2 (0.59) | CA2ALDH1A1POLBSMN1; SMN2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118076663-A | Composition and ink composition | 住友化学株式会社 | 2024-05-24 | — | — | CN | disclosed |
| EP-4368668-A1 | RESIN COMPOSITION | Sumitomo Chemical Company, Limited (JP) | 2024-05-15 | — | — | EP | disclosed |
| CN-117769897-A | Compound, composition, and photoelectric conversion element | 住友化学株式会社 | 2024-03-26 | — | — | CN | disclosed |
| EP-4024486-A1 | ORGANIC PHOTOELECTRIC CONVERSION MATERIAL | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2022-07-06 | — | — | EP | disclosed |
| CN-107109090-B | Ink composition and photoelectric conversion element produced using same | 住友化学株式会社 | 2021-10-08 | — | — | CN | disclosed |
| EP-2597932-B1 | MANUFACTURING METHOD FOR ORGANIC LIGHT-EMITTING DEVICE | SUMITOMO CHEMICAL CO (JP) | 2021-04-14 | — | — | EP | disclosed |
| EP-2680672-B1 | METHOD FOR PRODUCING ORGANIC ELECTROLUMINESCENT ELEMENT | SUMITOMO CHEMICAL CO (JP) | 2021-03-31 | — | — | EP | disclosed |
| EP-2605621-B1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND METHOD OF PRODUCING SAME | SUMITOMO CHEMICAL CO (JP) | 2020-07-15 | — | — | EP | disclosed |
| EP-2597933-B1 | MANUFACTURING METHOD FOR ORGANIC ELECTROLUMINESCENCE ELEMENT | SUMITOMO CHEMICAL CO (JP) | 2019-06-12 | — | — | EP | disclosed |
| US-10290809-B2 | Macromolecular compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2019-05-14 | — | — | US | disclosed |
| US-20120049167-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-03-01 | — | — | US | disclosed |
| EP-2423192-A1 | METAL COMPLEX HAVING AROMATIC LIGAND THAT CONTAINS NITROGEN ATOM | Sumitomo Chemical Company, Limited (JP) | 2012-02-29 | — | — | EP | disclosed |
| US-20120041203-A1 | METAL COMPLEX HAVING AROMATIC RING LIGAND CONTAINING NITROGEN ATOM | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-02-16 | — | — | US | disclosed |
| EP-2383814-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | Sumitomo Chemical Company, Limited (JP) | 2011-11-02 | — | — | EP | disclosed |
| US-20100264814-A1 | POLYMER COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2010-10-21 | — | — | US | disclosed |
| US-20100264812-A1 | METAL COMPLEX, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING DEVICE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-10-21 | — | — | US | disclosed |
| EP-2223949-A1 | POLYMER COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | Idemitsu Kosan Co., Ltd. (JP) | 2010-09-01 | — | — | EP | disclosed |
| EP-1932851-A1 | METAL COMPLEX, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING DEVICE | Sumitomo Chemical Company, Limited (JP) | 2008-06-18 | — | — | EP | disclosed |
| US-5736523-A | ADMINISTERING TO THE MAMMAL SUFFERING FROM CANCER | BIOCHEM PHARMA INC. (CA) | 1998-04-07 | — | — | US | disclosed |
| US-5606037-A | Processes antineoplastic heteronaphthoquinones | BIOCHEM PHARMA INC. (CA) | 1997-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10290809-B2 | Macromolecular compound | EXOSC4, TRPC6, MRPS22 | CA2 1030/4885ALDH1A1 3653/4885POLB 1868/4885 |
| US-20120041203-A1 | METAL COMPLEX HAVING AROMATIC RING LIGAND CONTAINING NITROGEN ATOM | MICA, CD4, CLTC | CA2 425/4885ALDH1A1 3458/4885POLB 2891/4885 |
| US-20100264812-A1 | METAL COMPLEX, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING DEVICE | SOD1, CRY1, YAP1 | CA2 2086/4885ALDH1A1 2442/4885POLB 3463/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.